PJP is trading at $137.83, up 4.74%, in pre-market; no clear catalyst for the rise has been identified.
- No clear company-specific announcement or news explaining PJPâs November 5 pre-market rise was found.
- Recent coverage notes the ETF holds U.S. pharmaceutical companies but identifies no new catalyst.
- Supplied market context is mixed and does not establish a broad-market explanation.